Achieving high immunogenicity against poliovirus with fractional doses of inactivated poliovirus vaccine in Ecuador-results from a cross-sectional serological survey.

Autor: Trueba G; University of San Francisco, Quito, Ecuador., Jeyaseelan V; Polio Eradication Department, World Health Organization, Avenue Appia 20, CH-1211 Genève 27, Geneva, Switzerland., Lopez L; University of San Francisco, Quito, Ecuador., Mainou BA; Division of Viral Diseases, Centres for Disease Control and Prevention, Atlanta, USA., Zhang Y; Division of Viral Diseases, Centres for Disease Control and Prevention, Atlanta, USA., Whittembury A; Pan American Health Organization, Ecuador., Valarezo AJO; Pan American Health Organization, Ecuador., Baquero G; National Polio Certification Commission, Ecuador., de Aguinaga RR; National Polio Certification Commission, Ecuador., Salinas LJZ; National Polio Certification Commission, Ecuador., Mancheno MGS; Ministry of Public Health, Ecuador., Chacho DEM; Ministry of Public Health, Ecuador., Quentin E; Universidad UTE, Ecuador., Chevez AE; Immunization Unit, Pan American Health Organization, Washington, USA., Rey-Benito G; Immunization Unit, Pan American Health Organization, Washington, USA., Mach O; Polio Eradication Department, World Health Organization, Avenue Appia 20, CH-1211 Genève 27, Geneva, Switzerland.

Publikováno v: Lancet regional health. Americas [Lancet Reg Health Am] 2022 Jul; Vol. 11, pp. None.